#CANNABIS: RENDE LE #MAMME SEMPLICEMENTE MIGLIORI

Diffondiamo tutti questo video per festeggiare la ormai prossima festa della #Donna, e riportare un po’ di speranza nel Presente e Futuro prossimo. “La cannabis rende le mamme migliori.” A dirlo sono le “Marijuana Moms”, uno dei tanti gruppi che sostengono attivamente la legalizzazione della cannabis. Per chi è abituato ai titoli da giornale, e quindi non è abituato a vedere al di là del proprio naso, il dire che “fumare cannabis” rende migliori è volontariamente provocatorio, perchè tutti questi gruppi promuovono tanti diversi tipi di assunzione della cannabis: usano il “fumare” perchè da sempre questo atto è stato demonizzato, quando in realtà la paura non ha modo di esistere.

 

► Moms for Marijuana, pagina internazionale dell’associazione: facebook.com/Moms4MJ/
► Link al video originale: facebook.com/BuzzFeedNews/videos/1097590893595261/

Annunci

La Terapia Gerson

‪#‎TESTIMONIANZA‬ DI EMANUELA ZONTA
IL MIO CAMMINO DI ‪#‎GUARIGIONE‬ DALLA ‪#‎SCLEROSI‬ ‪#‎MULTIPLA‬
Buongiorno Dott. Alessandro Nicolosi volevo ringraziarla per il risultato ottenuto dal suo protocollo fatto a pennello per me. Ho piacere nel fare questa testimonianza affinché altri malati possano chiedere aiuto a questo gentilissimo dottore e, aggiungo, molto preparato anche riguardo le malattie autoimmuni. Mi chiamo Emanuela, avevo seguito un seminario sulla Terapia Gerson a Robecco sul Naviglio, a seguito del fatto che alcuni mesi prima ebbi una paralisi a tutto il lato sinistro del corpo: faccia, lingua, braccia, schiena e gamba con successiva diagnosi di sclerosi multipla. ..poi mi ripresi un pò ma i dolori lancinanti mi portarono a dover vivere stesa sul letto. Non riuscivo neppure a sostenere più la testa e il bacino. I medici non fecero altro che farmi cortisone e morfina a dosaggi sempre più elevati, ecc…insomma ogni ora dovevo assumere un farmaco…così iniziai con il cellulare a farmi delle ricerche in Internet. Nel frattempo stavo malissimo, pensavo di morire, avevo il cuore continuamente in fibrillazione, problemi intestinali e urinari, sudorazione, mal di testa lancinante, formicolii ovunque, paralisi e dolori lancinanti. Finché iniziai la Terapia Gerson con succhi e clisteri, seguendo le istruzioni del libr, insomma, un “fai da me”. finché un giorno contattai il dott. Alessandro NICOLOSI che fu ed è la mia salvezza. Fece tutto un programma personalizzato in base alla mia malattia e alle mie problematiche e dopo neanche un mese, posso dire già di essere rinata. I miei dolori lancinanti sono scomparsi, ora riesco a camminare e pure a guidare…ed anche se non posso dire di essere guarita, dato che, in così poco tempo sarebbe impossibile, soprattutto per il fatto che la demielizzazione nel mio caso era ovunque. Ad oggi dovrei fare una risonanza per capire se si stia attuando un processo di riemielizzazione, ma in questo momento sarebbe troppo prematuro fare questo esame! La cosa più bella è ritornare a vivere senza più i farmaci che mi stavano uccidendo, poter camminare e non aver più dolori. Io posso solo ringraziare il dott.re che con la sua pazienza mi ha seguita giorno per giorno ed entrambe sappiamo che siamo solo all’inizio del percorso! Se io sono riuscita a far tutti questi progressi, lo devo al mio impegno ma anche a questo bravissimo dott.re. I miei vicini non mi vedevano mai, al massimo uscivo con la carrozzina per andare all’ospedale, dove giorno dopo giorno mi stavano uccidendo! Ai neurologi interessava solo farmi prendere sempre più farmaci anche se progressivamente stavano peggiorando la mia salute. Ora non ne prendo più, faccio solo succhi, clisteri e prendo gli integratori utilizzati in terapia. Spero che tutti i pazienti si rendano conto che la strada giusta per la guarigione non è quella proposta dalla medicina ufficiale ma una terapia sana come la propone Gerson e che, con questo sistema, potranno ottenere ottimi risultati. Ogni mattino mi sveglio e mi auguro di star bene come in questi giorni e sono felicissima di alzarmi, mangiarmi una mela per poi andare a fare il clistere. Poi sveglio i miei figli e preparo la loro colazione, quando prima se la dovevano fare da soli. Sentirmi di nuovo mamma è un emozione cosi grande che non riesco neppure a descrivere ma quando da disabili si ritornarna ad essere autosufficienti non c’è niente che possa eguagliare questa sensazione! Mi sento appagata e orgogliosa per non aver mai mollato! Ora sono i miei figli che mi dicono : “mamma hai fatto il succo oppure vai a farti il clistere così starai sempre meglio”. All’inizio erano contrari a questa terapia e mi chiedevano perché non prendessi più le pastiglie (premetto che i miei figli hanno 11 e 13 anni) così io gli spiegai che le mie medicine erano i succhi e i clisteri. Oggi però capiscono che la mamma ha scelto la strada giusta! Dopo un anno e mezzo la mamma non vive più a letto! Ringrazio Margaret Straus per aver tenuto il seminario, Mariagrazia Personeni per il kit Earthing che continuo ad utilizzate e soprattutto, il dott.re Alessandro Nicolosi, che è davvero unico, sempre gentile, calmo, paziente e che spiega al dettaglio tutto il da farsi con una grande dedizione e amore per il suo lavoro. Grazie a tutti e prego ai pazienti di contattare immediatamente queste persone che possono aiutarvi ad arrivare alla guarigione. Io l’ho fatto e prego e ringrazio Dio che esistano persone che instancabilmente lottano assieme a te per il tuo bene!
Grazieee mille

MANUELA

AUTORE: EMANUELA ZONTA

 

http://www.metodogerson.org/

Margaret Straus

Margaret Sraus da anni porta avanti, insieme alla madre Charlotte e al fratello Howard, il lavoro del nonno, il Dottor Max Gerson. Vive in Italia ed è impegnata nella diffusione della Terapia per la prevenire e la cura del tumore e di alre malattie cosiddette “incurabili”.

MARGARET STRAUS
Partecipa a seminari informativi e fornisce supporto a chi vuole applicare il Protocollo alimentare del dottor Gerson.

Il metodo Gerson contro il cancro. Intervista a Margaret Straus Max Gerson il nemico della medicina - parte prima

 

 

 

California GOP Congressman Is a Medical Marijuana Patient |

Congressman Dana Rohrabacher has long been friendly to medical marijuana. In fact, he’s the co-sponsor of an important piece of legislation that bears his name: the Hinchey-Rohrabacher medical marijuana amendment stops the federal government from spending money to enforce federal laws in legal medical marijuana states. He’s also a supporter of legalizing recreational marijuana in California.

 

Even with all this, Rohrabacher’s public declaration that he’s a medical marijuana patient absolutely stunned the activists at a NORML gathering in Washington DC.

According to Russ Belville, Congressman Rohrabacher said that he’s had severe arthritis pain in his shoulder due to many decades of surfing. Just like many other people, he went to a hempfest in San Bernadino and found relief from a topical product containing cannabis…no smoking required.

This is big. It’s the first time since Ronald Reagan was in office that a sitting U.S. Congressperson has admitted to using marijuana. And Congressman Rohrabacher is not just saying he smoked pot as a college student; he’s talking about using medical marijuana legallynow as a California patient…just like I (and possibly you) do. And he’s a Republican, which just shows that pain and suffering, as well as compassion, knows no political boundaries.

Sorgente: California GOP Congressman Is a Medical Marijuana Patient |

Say YES to cannabis as Medicine!

Some statements in support of the MCD (in alphabetical order)

“Cannabis has been a medicine for a lot longer than it hasn’t been. Now that the evidence is mounting to support its effectiveness in a number of clinical conditions, the information must be disseminated. Support the Medical Cannabis Declaration and help spread the word. Knowledge=Power!”

Dr. Donald I. Abrams, Rofessor, University of California in San Francisco, USA

“The Medical Cannabis Declaration (MCD) is on the front line of medical Cannabis information and patient rights. It has been over a decade since Cannabis is recognized as medicine by the highest scientific authority on Earth. With the support of the International Association for Cannabinoids as Medicine (IACM), the MCD is able to gather to most advanced and reliable scientific information to doctors and patients, in order to help them understand the potential and the use of Cannabis as a Medicine. That is why, as a patient and Cannabis researcher, I fully support the MCD ‘s excellent initiative, and I encourage you to do the same in showing your support by making a donation. Together we can make medical Cannabis a reality throughout the world. “

Sébastien Béguerie, MA, UFCM (Union Francophone pour les Cannabinoïdes en Médecine), , France

“I support The Medical Cannabis Declaration, because our current drug-laws around the world are in direct conflict with one of our most basic rights. The right to access equal safe medical treatment and medicine, such as cannabis.”

Svein Berg, Cannabis Patient, Norway

“As head of the Swiss Taskforce for Cannabinoids in Medicine (STCM) I expressly encourage everybody to sponsor MCD. Promoting and facilitating the access of medical cannabis and cannabinoids to patients worldwide is essential and requires adequate financial support.”

Dr. Rudolf Brenneisen, Professor, University of Bern, Switzerland

“Access to Cannabis and its derivative as medicine is definitely a Human Right as stated in the declaration, this could literally help millions of people suffering worldwide. Donate is important because it will help us to spread the truth on medical potentials and benefits of Cannabis explaining to most how it works!”

Laurent A. J. Campos, Cannabis Patient, Brazil

“For so long cannabis has been prohibited. A long battle managed by some strong-minded idealists draws to a close with a great success. That’s because I encourage MCD. Let’s support together our efforts for a better health!”

Dr. Jean Colombera, General Practitioner, Luxembourg

“It’s important that patients around the world have help in overcoming the unwarranted legal and bureaucratic obstacles to obtaining cannabis as medicine. I can think of no one more qualified than MCD in undertaking this task.”

Dr. Dale Gieringer, NORML California, USA

“The great power of words and the spreading of information could help so much the Medical Cannabis Declaration and the crowdfunding initiative, but to give more opportunity to the great work of many people and scientists involved in medicinal Cannabis and its rising in all over the world some financial support is need and so please add your financial help to the MCD efforts. “

Dr. Gianpaolo Grassi, SIRCA (Società Italiana Ricerca Cannabis), Italy

“Many of those who staunchly defend the prohibition against marijuana believe we do not yet know enough about it to be able to make the kinds of decisions that are now necessary. Despite the US government’s three-quarter-century-long prohibition of marijuana and its confinement to schedule 1 of the Drug Control and Abuse Act of 1970, it is nonetheless one of the most studied therapeutically active substances in history; to date there are more than 23,000 published studies or reviews in the scientific literature referencing the cannabis plant and its cannabinoids, more than half of which were published within the past five years. By contrast, hydrocodone, a pharmaceutical opioid which is responsible for a large and growing number of overdose deaths from illicit use, yields just more than 600 references in the entire compilation of the available scientific research. It is high-time that we as a civilized society reconsider our views of this remarkable substance.”

Dr Lester Grinspoon, Associate Professor, Harvard Medical School, USA

“Many people around the world suffer unnecessarily because they don’t have access to medical cannabis. Support the MCD crowdfunding campaign to change this unfair situation!”

Dr.. Manuel Guzman, Professor, Computense Univiversity Madrid, Spain

“As a physician in the USA approving the use of cannabis for many medical conditions for nearly 20 years I believe the MCD is of great pivotal importance in making this exceptionally safe and effective medicine available around the world. “

Dr Jeffrey Hergenrather, USA

“The endogenous cannabinoid system is a unique signaling system with a central and protagonist role in the coordination of virtually any organic aspect underling homeostasis maintenance. Therefore, I believe it is an ethical obligation for health professionals and scientists to support both the research and the effective application of the many therapeutic properties of Cannabis and its derivatives. For this reason, I strongly support the Medical Cannabis Declaration and ask everybody to donate and collaborate to this endeavor.”

Dr Renato Malcher, University Brasilia, Brazil

“Patients Out of Time receives countless emails from desperate patients or their family members from all over the world seeking access to medical cannabis. History and science support the therapeutic value of this natural herbal medicine. Please give what you can to help support the Medical Cannabis Declaration so that all of our voices can help end the cannabis prohibition on a global level.”

Mary Lynn Mathre, President of Patients Out of Time, USA

“I strongly support the Medical Cannabis Declaration. We know now that cannabinoids have a wide spectrum of therapeutic effects which can help a huge number of patients. We should try to make the published knowledge widely available so that patients as well as regulatory bodies be aware of the therapeutic possibilities. In Israel there are now about 25,000 patients who get medical cannabis officially. This was made possible because physicians learned about the medical properties of medical cannabis (of various, well defined varieties). We should make every effort to bring this medical information to patients and physicians in many countries. Please donate to make this possible. “

Dr. Raphael Mechoulam, Professor, Hebrew University, Israel

“Many patients suffer from severe, disabling, and otherwise treatment resistant diseases. In some of these patients, medical cannabis can ameliorate their symptoms and therefore can help to improve patients’ quality of life. Support the Medical Cannabis Declaration and help to facilitate access of medical cannabis.”

Dr Kirsten Müller-Vahl, Professor, Medical School of Hannover, Germany

“The persecution and prosecution of people who use cannabis for medical purposes has long been the most egregious component of the prohibitionist approach to cannabis policy. The Medical Cannabis Declaration merits the support of all those who support science over ignorance, and compassion over punishment.”

Dr Ethan Nadelmann, Executive Director, Drug Policy Alliance, USA

”As a doctor I feel that it is my moral and ethical obligation to support the campaign for medicinal cannabis because of the scientific evidence of the therapeutic properties of cannabis and its derivatives. I would like to motivate everybody to donate to this campaign and thus allow all patients, who need it access to therapeutic cannabis.”

Dr Ricardo Navarrete-Varo, Spain

“Denying medical cannabis is one of the worst outrages in the history of medicine. The ban on cannabis was purely a political act and should be reversed immediately.”

Dr David Nutt, Professor, UK

“I firmly believe that The Medical Cannabis Declaration (MCD) charity greatly helps with meeting the important and rapidly growing need to educate clinicians about the established benefits and risks of cannabinoid medicines so that they can provide the best possible care for their patients. This is of course particularly important for patients with disorders for which there is no known non-cannabinoid treatment that is both sufficiently effective and safe.”

Dr Roger Pertwee, Professor, University Aberdeen, UK

“The Medical Cannabis Declaration (MCD) is a brilliant initiative, demanding to allow an open access for this essential therapeutic substance (Marijuana/Cannabis), for physicians and their patients, willing to use it in order to reach identifiable treatment aims and goals, collaborating mutually.
“In order to promote these important tasks, I call for overwhelming support and generous donation for the MCD Initiative.”

Dr Ilya Reznik, Israel

“I have been a researcher in the area of medical applications of cannabis for the last 20 years. I have seen the great relief that it can bring to a large number of intractable medical conditions, and that is the reason that I support the Medical Cannabis Declaration and ask that people around the world contribute funds towards its goals.”

Dr med Ethan Russo, Professor, USA

“I support the Declaration on Medicinal Cannabis because as a doctor I can assure that there is no medicinal plant as safe in use and with so many therapeutic applications such as Cannabis Sativa . Do not allow both humanity and other members of the animal kingdom can benefit from this scientific reality must be considered an attack on the overall health of all living beings that inhabit the planet Earth.”

Dr Javier Pedraza Valiente, Portugal

Responsible under press legislation (V.i.S.d.P.):
Medical Cannabis Declaration e.V.
Am Mildenweg 6, 59602 Ruethen, Germany
Authorized representative, responsible for the content, privacy and Youth Protection Officer:
Dr. med. Franjo Grotenhermen
info@medical-cannabis-declaration.org

http://www.medical-cannabis-declaration.org

mcd-header-960x221

http://medical-cannabis-declaration.org/?lang=it

Jason Pinsky is Fighting to Improve the Cannabis Landscape

Jason Pinsky is a passionate advocate for cannabis legislation in New York. His own personal struggle to overcome a dependency to OxyContin after spinal surgery 15-years ago thrusted him into the cannabis advocacy and legislation sphere.  He was instrumental in the 2014 legislation that legalized cannabis for a select few within the state, and now he wants to improve the program so that everyone who needs medical cannabis can get it.

A Brooklyn resident, Pinsky owns the popular BBQ restaurant Fette Sau. He also serves as CEO of Cannastract, a company that focuses on bringing science to cannabis extracts and concentrates.  CULTURE got a chance to interview Pinsky about  his goals for the future of cannabis in New York, and why he feels that this generation will finally shatter the myths and stereotypes that are blocking the way for cannabis legalization in America.

When did you first discover the medicinal benefits of cannabis?

I’ve been using cannabis since high school, but in 2012 I started educating myself on extracts and concentrates. I attended my first Cannabis Cup as a judge in 1994 and was able to return 20 years later in 2014 to judge the concentrate category in every market. My time as a judge for the Cannabis Cup allowed me to experience high quality products. It was during this time that I challenged myself to lose 100 pounds and become 100 percent free of the pain medication I was taking. I achieved both goals in October of 2014.

Why were you taking pain medication?

I had spinal surgery in 2000 and was involved in a motorcycle accident in 2012. I was prescribed OxyContin, and needed to increase the dosage constantly as I developed a tolerance to it. At one point, I was taking over 1000-mg of OxyContin a day. Cannabis allowed me to manage my pain without the negative side effects of the pain medication.

You’re fighting to increase the availability of medical cannabis in New York. How is it going?

I was an active part of the 2014 legislation that allowed for medical cannabis in limited cases. Back in 2014, opiates weren’t part of the story. It was more about getting medical cannabis in the hands of the seriously ill or children with epilepsy. Recently though, the opiate epidemic has become a serious issue—and with my background—I am trying to educate law makers on the positive effects cannabis has on getting you off of prescription pain medications. Our goal is to allow for more patient access, especially for people suffering from severe chronic pain.

Jason2Is there a state you would like to model New York’s cannabis legislation after?

I think Colorado has the best model in the country. They have a regulated program with numerous options for distribution and production.

You’re also working behind the cannabis scenes as CEO of Cannastract, can you tell us about that?

Cannastract is a company that does consulting on the genetics, cultivation and processing of cannabis. We’re a New York-based crew that features a lot of the earlier pioneers of strains like Chemdog and Sour Diesel. Since 2013, we have seen a leap in processing and development of better strains of cannabis. Cannastract’s focus is in the chemistry of cannabis, which really helps in this endeavor.

You appeared on a recent episode of VICE, how did that come about?

I know several producers at VICE. I was attending a High NY event, a monthly cannabis meet-up, and I ran into one of the producers working on a cannabis piece. They were looking to examine cannabis from a patient, dispensary and doctor’s perspective. I told them that I am deep in the trenches of the cannabis legislation in New York and that we should collaborate. They decided to follow me as I met with lawmakers to discuss changes to the current cannabis laws.  They had 15 hours of footage that they edited down to the five minute piece you see online.

What is your long term hope for cannabis?

The real push should be to de-schedule cannabis, not re-schedule it. If the DEA simply re-schedules cannabis, it will only benefit big pharma, but if you de-schedule it, it will benefit everyone. It will allow for further research and for an increase in access to patients. Long term, I would love to see people educated on how cannabis can help you achieve homeostasis. For them to learn the health benefits of supplementing cannabis into their lives, like drinking eight glasses of water a day. Cannabis has been around for thousands of years, and has only been vilified in the last hundred years. Hopefully, my story can help educate others about the healing power of cannabis.

Are you optimistic that we can reach these goals?

Yeah! It’ll probably take a generational shift though. My son’s generation will be brought up with the ideals that cannabis is a medicinal plant and not a great evil. It’s that shift in logic that will lead to the major change we need.

 http://www.vice.com/video/why-activists-are-working-to-expand-new-yorks-medical-marijuana-program

Sorgente: Jason Pinsky is Fighting to Improve the Cannabis Landscape

Insys Therapeutics Successfully Completes Safety and Pharmacokinetic (PK) Study of Cannabidiol Oral Solution in Pediatric Epilepsy Patients

Insys Therapeutics, Inc. (NASDAQ: INSY) (“Insys” or “the Company”) today announced that it has successfully completed its Phase 1/Phase 2 safety and pharmacokinetic (PK) study in pediatric subjects with treatment-resistant epilepsy.

Insys-Therapeutics-500x281

In this trial, 61 subjects with refractory epilepsy, between the ages of 1 year to 17 years, received treatment with Insys’ pharmaceutical cannabidiol (CBD) oral solution across multiple investigative sites in the United States. The clinical trial evaluated multiple ascending doses of Insys’ CBD with three cohorts of subjects receiving total daily doses of 10 mg/kg, 20 mg/kg or 40 mg/kg. Over 80% of these subjects continue to receive CBD in an ongoing long-term safety study.

“We are excited that our synthetic pharmaceutical CBD in a non-alcoholic, medium chain triglyceride-based formulation was studied up to a daily dose of 40 mg/kg in subjects with pediatric epilepsy. The data is currently under analysis, and the CBD appears to have been generally well tolerated,” said Dr. John N. Kapoor, Chairman, President and Chief Executive Officer of Insys Therapeutics.

“We anticipate meeting with the FDA to discuss the subsequent steps for this program, as well as the development program for the treatment of Dravet syndrome and Lennox-Gastaut syndrome, two rare forms of pediatric epilepsy for which Insys’ pharmaceutical CBD formulation received orphan drug designation. Additionally, we have an ongoing trial evaluating CBD in infantile spasms, a catastrophic form of childhood epilepsy. These efforts underscore our commitment to advancing our pharmaceutical CBD program in pediatric epilepsy and we look forward to updating you on our progress in due course,” added Dr. Kapoor.

About the Study
The main protocol inclusion criteria included:

Male or female between 1 and 17 years of age (inclusive)
Diagnosed with a treatment-resistant seizure disorder
Additional details of the study may be found here.

About Pharmaceutical CBD
Insys’ pharmaceutical CBD is over 99.5% pure cannabidiol. It is synthesized to be chemically identical to the CBD extracted from cannabis, and is produced in a controlled environment. The FDA issued a Drug Master File (DMF) to Insys for its CBD active pharmaceutical ingredient in May 2014.

About Dravet Syndrome
Dravet syndrome, also known as Severe Myoclonic Epilepsy of Infancy, is a rare and catastrophic form of intractable epilepsy that begins in infancy. Initial seizures are most often prolonged events and in the second year of life other seizure types begin to emerge. Development remains on track initially, with plateaus and a progressive decline typically beginning in the second year of life. Individuals with Dravet syndrome face a higher incidence of SUDEP (sudden unexplained death in epilepsy) and have associated conditions, which also need to be properly treated and managed.

About Lennox-Gastaut Syndrome
Lennox-Gastaut syndrome is a severe form of childhood-onset epilepsy that typically manifests between two and six years of age. The syndrome is characterized by multiple seizure types, moderate to severe cognitive impairment, and an abnormal EEG. The frequency and severity of seizures vary by individual. It is often treated with, but has proved resistant to, various anti-seizure medications. There is no cure for the syndrome at this time.

About Insys Therapeutics, Inc.
Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative drugs and novel drug delivery systems of therapeutic molecules that improve the quality of life of patients. Using proprietary sublingual spray technology and capabilities to develop pharmaceutical cannabinoids, Insys addresses the clinical shortcomings of existing commercial products. Insys currently markets one product, Subsys® (fentanyl sublingual spray). The Company submitted a New Drug Application to the U.S. Food and Drug Administration for SyndrosTM (dronabinol oral solution), a proprietary, orally administered liquid formulation of dronabinol that Insys believes has distinct advantages over the current formulation of dronabinol in soft gel capsule. Insys is developing a pipeline of sublingual sprays, as well as pharmaceutical cannabidiol.

Subsys® and SyndrosTM are trademarks of Insys Therapeutics, Inc.

Forward-Looking Statements
This press release contains forward-looking statements regarding our belief that our CBD product appears to have been generally well tolerated; our expectations that we will be meeting with the FDA about our CBD program; and our belief that Syndros™ has distinct advantages over the current formulation of dronabinol in soft gel capsule. These forward-looking statements are based on management’s expectations and assumptions as of the date of this press release; actual results may differ materially from those in these forward-looking statements as a result of various factors, many of which are beyond our control. These factors include, but are not limited to risk factors described in our filings with the United States Securities and Exchange Commission, including those factors discussed under the caption “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2015 and subsequent updates that may occur in our Quarterly Reports on Form 10-Q. Forward-looking statements speak only as of the date of this press release and we undertake no obligation to publicly update or revise these statements, except as may be required by law.

http://420intel.com/articles/2016/05/25/insys-therapeutics-successfully-completes-safety-and-pharmacokinetic-pk-study?utm_source=420+Intel+-+Marijuana+Industry+News&utm_campaign=3daf553b66-420+Intel&utm_medium=email&utm_term=0_3210cbef52-3daf553b66-270890321

Could Marijuana Help Treat Huntington’s Disease?

While at least one study has suggested that cannabinoid therapy could help treat symptoms of Huntington’s Disease, the first-ever clinical trial investigating the efficacy of cannabis extracts in treating the disease was less than positive.

1200x600_23

Huntington’s, the debilitating, scary neurodegenerative disorder that claimed the lives of both musician Woody Guthrie and renowned NBC journalist Charles Sabine, destroys neurons in the basal ganglia – the area of the brain which controls movement, cognition, and normal psychiatric functioning.

In addition to the psychomotor symptoms, sufferers frequently experience depression that causes many to commit suicide. There is no known cure for the disease, although medications can help manage it.

The double-blind, placebo-controlled study, completed at the Ramon y Cajal University Hospital’s Foundation for Biomedical Investigation in Madrid, was commissioned by the makers of the prescription cannabinoid spray Sativex.

It showed that while cannabinoids are safe to administer to Huntington’s Disease sufferers, there was no statistical difference in motor or cognitive deficits after treatment with the drug.

Marijuana can alleviate some symptoms

That being said, as Medical Jane points out, while cannabinoids might not help with the mental and motor symptoms, medical marijuana could help alleviate other symptoms, like pain caused by dystonia, sleepdisturbance, depression, and anxiety.

The authors of the Ramon y Cajal University Hospital’s Foundation study recommended further investigation of cannabinoid therapy for Huntington’s Disease, using higher doses for more prolonged periods of time.

http://420intel.com/articles/2016/05/25/could-marijuana-help-treat-huntingtons-disease?utm_source=420+Intel+-+Marijuana+Industry+News&utm_campaign=3daf553b66-420+Intel&utm_medium=email&utm_term=0_3210cbef52-3daf553b66-270890321

Why do some Colorado politicians oppose medical pot for veterans?

The U.S. House, Senate have voted to allow VA doctors to talk medical marijuana with patients, but two state ‘no’ votes point to conflicts with federal prohibition as a potential problem

PTSD

 

By Mark Matthews, The Denver Post

WASHINGTON — In two separate actions, the U.S. House and Senate this week moved to make it easier for military veterans to access medical marijuana — efforts that were largely, but not unanimously, supported by Colorado’s congressional delegation.

The first step was a House vote Thursday on an amendment to a budget bill for the VA and military construction that would allow doctors with the U.S. Department of Veterans Affairs to recommend pot as treatment to veterans in states where medical marijuana is legal, which is roughly half the country.

The Senate took a similar approach in its own version of the spending measure by neutering a VA policy that had prohibited this practice.

Peruse our Cannabist-themed merchandise (T’s, hats, hoodies) at Cannabist Shop.

9a6d5e20-6435-4c9d-89f1-ca78829f16af-medium

Both measures easily passed their respective chambers.

The House approved the marijuana amendment by a 233-189 vote and the Senate on Thursday passed its spending measure, in which the pot policy change was included, by an 89-8 margin.

Five of Colorado’s seven lawmakers in the House supported the amendment, including U.S. Rep. Jared Polis, D-Boulder, who co-authored the provision.

“Veterans whose doctors believe that medical marijuana will help them address medical issues such as PTSD (post-traumatic stress disorder) or chronic pain should be afforded that option,” said Polis in a statement.

Another supporter of the House amendment was veteran and U.S. Rep. Mike Coffman, R-Aurora.

He said in a phone interview that the marijuana provision wasn’t an easy vote but — given the number of combat veterans dealing with PTSD — that he’s willing to give it a try.

“I tend to be more open on alternative therapies,” he said.

The state’s two no votes were from U.S. Reps. Doug Lamborn, R-Colorado Springs, and Scott Tipton, R-Cortez. Both pointed to the fact that marijuana remains listed as a federally controlled substance as a reason to oppose it.

“It’s bad policy to place VA doctors (who are federal employees) in a position where they could potentially violate federal law by discussing/prescribing medical marijuana,” said Tipton aide Josh Green in a statement.

veterans-march7veterans-march3

Colorado’s two U.S. Senators, Michael Bennet and Cory Gardner, both supported the underlying bill with the marijuana provision.

One of the nation’s biggest veteran groups, the Veterans of Foreign Wars, has taken a wait-and-see approach to the legislation.

“It is illegal by federal law, but if proven to help sick or disabled veterans, then perhaps the federal government should allow it, provided its effects do not compromise existing treatments or medications prescribed by licensed medical professionals,” said spokesman Joe Davis. “More research needs to be done.”

 

Why do some Colorado politicians oppose medical pot for veterans?

This story was first published on DenverPost.com